PEG-g-chitosan thermosensitive hydrogel for implant drug delivery: Cytotoxicity, in vivo degradation and drug release

Journal of Biomaterials Science, Polymer Edition

Volumn 25, Issue 3, 2014, Pages 241-256

  Jiang, Guoqiang ^a   Sun, Jiali ^a   Ding, Fuxin ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Biocompatibility; Cyclosporine A; Drug delivery; Drug release; Thermosensitive hydrogel

Indexed keywords

CYCLOSPORINE A; DRUG CONCENTRATION; DRUG RELEASE; FIBROSARCOMA CELLS; INFLAMMATORY RESPONSE; SPRAGUE-DAWLEY RATS; SUSTAINED RELEASE; THERMO-SENSITIVE HYDROGEL;

BIOCHEMISTRY; BIOCOMPATIBILITY; BLOOD; CELL CULTURE; CHITOSAN; CYTOTOXICITY; DRUG DELIVERY; DRUG PRODUCTS; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES;

HYDROGELS;

CHITOSAN; CYCLOSPORIN A; MACROGOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENCAPSULATION; HEAT SENSITIVITY; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RAT; SUSTAINED DRUG RELEASE;

MURINAE; RATTUS;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL LINE, TUMOR; CHITOSAN; CYCLOSPORINE; DRUG CARRIERS; DRUG IMPLANTS; HYDROGEL; MALE; MICE; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; TEMPERATURE;

EID: 84892365366     PISSN: 09205063     EISSN: 15685624     Source Type: Journal    
DOI: 10.1080/09205063.2013.851542     Document Type: Article

References (38)

1. Li Z, Guan J. Thermosensitive hydrogels for drug delivery. Expert Opin. Drug Delivery. 2011;8:991-1007.
2. Wei L, Cai CH, Lin JP, Chen T. Dual-drug delivery system based on hydrogel/micelle composites. Biomaterials. 2009;30:2606-2613.
3. Bhattarai N, Gunn J, Zhang MQ. Chitosan-based hydrogels for controlled, localized drug delivery. Adv. Drug Delivery Rev. 2010;62:83-99.
4. Jin R, Teixeira LSM, Dijkstra PJ, Karperien M, van Blitterswijk CA, Zhong ZY, Feijen J. Injectable chitosan-based hydrogels for cartilage tissue engineering. Biomaterials. 2009;30:2544-2551.
5. Azab AK, Orkin B, Doviner V, Nissan A, Klein M, Srebnik M, Rubinstein A. Crosslinked chitosan implants as potential degradable devices for brachytherapy: in vitro and in vivo analysis. J. Controlled Release. 2006;111:281-289.
6. Wang Y, Chen M, Li X, Huang Y, Liang W. A hybrid thermo-sensitive chitosan gel for sustained release of Meloxicam. J. Biomater. Sci., Polym. Ed. 2008;19:1239-1247.
7. Zan J, Chen HH, Jiang GQ, Lin Y, Ding FX. Preparation and properties of crosslinked chitosan thermosensitive hydrogel for injectable drug delivery systems. J. Appl. Polym. Sci. 2006;101:1892-1898.
8. Ruel-Gariepy E, Shive M, Bichara A, Berrada M, Le Garrec D, Chenite A, Leroux JC. A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. Eur. J. Pharm. Biopharm. 2004;57:53-63.
9. Shu XZ, Zhu KJ. Controlled drug release properties of ionically cross-linked chitosan beads: the influence of anion structure. Int. J. Pharm. 2002;233:217-225.
10. Tosatti S, De Paul SM, Askendal A, Vande Vondele S, Hubbell JA, Tengvall P, Textor M. Peptide functionalized poly(L-lysine)-g-poly(ethylene glycol) on titanium: resistance to protein adsorption in full heparinized human blood plasma. Biomaterials. 2003;24:4949-4958.
11. Hoemann CD, Sun J, Legare A, McKee MD, Buschmann MD. Tissue engineering of cartilage using an injectable and adhesive chitosan-based cell-delivery vehicle. Osteoarthr. Cartilage. 2005;13:318-329.
12. Bhattarai N, Ramay HR, Gunn J, Matsen FA, Zhang MQ. PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release. J. Controlled Release. 2005;103:609-624.
13. Bhattarai N, Matsen FA, Zhang M. PEG-grafted chitosan as an injectable thermoreversible hydrogel. Macromol. Biosci. 2005;5:107-111.
14. Liang Y, Deng L, Chen C, Zhang J, Zhou R, Li X, Hu R, Dong A. Preparation and properties of thermoreversible hydrogels based on methoxy poly(ethylene glycol)-grafted chitosan nanoparticles for drug delivery systems. Carbohydr. Polym. 2011;83:1828-1833.
15. Molinaro G, Leroux JC, Damas J, Adam A. Biocompatibility of thermosensitive chitosanbased hydrogels: an in vivo experimental approach to injectable biomaterials. Biomaterials. 2002;23:2717-2722.
16. Sun JL, Jiang GQ, Qiu TT, Wang YJ, Zhang K, Ding FX. Injectable chitosan-based hydrogel for implantable drug delivery: body response and induced variations of structure and composition. J. Biomed. Mater. Res., Part A. 2010;95A:1019-1027.
17. Sun J, Jiang G, Wang Y, Ding F. Thermosensitive chitosan hydrogel for implantable drug delivery: blending PVA to mitigate body response and promote bioavailability. J. Appl. Polym. Sci. 2012;125:2092-2101.
18. Harris JM, Struck EC, Case MG, Paley MS, Vanalstine JM, Brooks DE. Synthesis and characterization of Poly(Ethylene Glycol) derivatives. J. Polym. Sci., Part A: Polym. Chem. 1984;22:341-352.
19. Inukai Y, Chinen T, Matsuda T, Kaida Y, Yasuda SJ. Selective separation of germanium (IV) by 2,3-dihydroxypropyl chitosan resin. Anal. Chim. Acta. 1998;371:187-193.
20. Stammen JA, Williams S, Ku DN, Guldberg RE. Mechanical properties of a novel PVA hydrogel in shear and unconfined compression. Biomaterials. 2001;22:799-806.
21. Ren DW, Yi HF, Wang W, Ma XJ. The enzymatic degradation and swelling properties of chitosan matrices with different degrees of N-acetylation. Carbohydr. Res. 2005;340:2403-2410.
22. Dai JD, Nagai T, Wang XQ, Zhang T, Meng M, Zhang Q. pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A. Int. J. Pharm. 2004;280:229-240.
23. Chimalakonda AP, Shah RB, Mehvar R. High-performance liquid chromatographic analysis of cyclosporin A in rat blood and liver using a commercially available internal standard. J. Chromatogr. B-Anal. Technol. Biomed. Life Sci. 2002;772:107-114.
24. Philippova OE, Volkov EV, Sitnikova NL, Khokhlov AR, Desbrieres J, Rinaudo M. Two types of hydrophobic aggregates in aqueous solutions of chitosan and its hydrophobic derivative. Biomacromolecules. 2001;2:483-490.
25. Ruiz-Caro R, Veiga MD, Di Meo C, Cencetti C, Coviello T, Matricardi P, Alhaique F. Mechanical and drug delivery properties of a chitosan-tartaric acid hydrogel suitable for biomedical applications. J. Appl. Polym. Sci. 2012;123:842-849.
26. Mehrotra S, Lynam D, Liu C, Shahriari D, Lee I, Tuszynski M, Sakamoto J, Chan C. Time controlled release of arabinofuranosylcytosine (Ara-C) from agarose hydrogels using layer-by-layer assembly: an in vitro study. J. Biomater. Sci., Polym. Ed. 2012;23:439-463.
27. Goreish HH, Lewis AL, Rose S, Lloyd AW. The effect of phosphorylcholine-coated materials on the inflammatory response and fibrous capsule formation: In vitro and in vivo observations. J. Biomed. Mater. Res., Part A. 2004;68A:1-9.
28. Su J, Hu B-H, Lowe WL, Jr., Kaufman DB, Messersmith PB. Anti-inflammatory peptide-functionalized hydrogels for insulin-secreting cell encapsulation. Biomaterials. 2010;31:308-314.
29. He W, McConnell GC, Schneider TM, Bellamkonda RV. A novel anti-inflammatory surface for neural electrodes. Adv. Mater. 2007;19:3529-3533.
30. Kang GD, Cheon SH, Khang G, Song SC. Thermosensitive poly(organophosphazene) hydrogels for a controlled drug delivery. Eur. J. Pharm. Biopharm. 2006;63:340-346.
31. Cabrera MI, Grau RJA. A generalized integral method for solving the design equations of dissolution/diffusion-controlled drug release from planar, cylindrical and spherical matrix devices. J. Membr. Sci. 2007;293:1-14.
32. Ptachcinski RJ, Venkataramanan R, Burckart GJ. Clinical pharmacokinetics of cyclosporine. Clin. Pharmacokinet. 1986;11:107-132.
33. Kahan BD. Drug therapy -cyclosporine New England. J. Med. 1989;321:1725-1738.
34. Woo JS, Piao MG, Li DX, Ryu D-S, Choi JY, Kim J-A, Kim JH, Jin SG, Kim D-D, Lyoo WS, Yong CS, Choi H-G. Development of cyclosporin A-loaded hyaluronic microsphere with enhanced oral bioavailability. Int. J. Pharm. 2007;345:134-141.
35. Malaekeh-Nikouei B, Tabassi SAS, Jaafari MR. Preparation, characterization, and mucoadhesive properties of chitosan-coated microspheres encapsulated with cyclosporine A. Drug Dev. Ind. Pharm. 2008;34:492-498.
36. Hirunpanich V, Sato H. Improvement of cyclosporine A bioavailability by incorporating ethyl docosahexaenoate in the microemulsion as an oil excipient. Eur. J. Pharm. Biopharm. 2009;73:247-252.
37. Onoue S, Sato H, Kawabata Y, Mizumoto T, Hashimoto N, Yamada S. In vitro and in vivo characterization on amorphous solid dispersion of cyclosporine A for inhalation therapy. J. Controlled Release. 2009;138:16-23.
38. Lee SS, Kim H, Wang NS, Bungay PM, Gilger BC, Yuan P, Kim J, Csaky KG, Robinson MR. A pharmacokinetic and safety evaluation of an episcleral cyclosporine implant for potential use in high-risk keratoplasty rejection. Invest. Ophthalmol. Visual Sci. 2007;48:2023-2029.